Somewhat Favorable Press Coverage Somewhat Unlikely to Affect AmerisourceBergen Corporation (Holding Co) (ABC) Share Price
Headlines about AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. AmerisourceBergen Corporation (Holding Co) earned a coverage optimism score of 0.14 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.4636809447024 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the headlines that may have impacted Accern’s analysis:
- Pharmerica Corporation (NYSE:PMC) vs. AmerisourceBergen Corporation (Holding Co) (ABC) Critical Contrast – The Momentous News (momentousnews.com)
- AmerisourceBergen Corporation (Holding Co) (ABC) Announces $0.37 Quarterly Dividend (americanbankingnews.com)
- Analysts Expect AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) Will Announce Quarterly Sales of $40.28 Billion (americanbankingnews.com)
- AmerisourceBergen Corporation (Holding Co) (ABC) Upgraded at Zacks Investment Research (americanbankingnews.com)
- $1.34 Earnings Per Share Expected for AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) This Quarter (americanbankingnews.com)
AmerisourceBergen Corporation (ABC) traded down 1.15% during trading on Thursday, reaching $78.88. The company had a trading volume of 2,417,110 shares. AmerisourceBergen Corporation has a 52 week low of $68.38 and a 52 week high of $97.85. The firm has a market capitalization of $17.28 billion, a price-to-earnings ratio of 20.55 and a beta of 0.91. The company’s 50-day moving average is $91.85 and its 200 day moving average is $89.29.
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) last posted its earnings results on Thursday, August 3rd. The company reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.06. The company had revenue of $38.71 billion during the quarter, compared to analysts’ expectations of $39.13 billion. AmerisourceBergen Corporation (Holding Co) had a return on equity of 56.07% and a net margin of 0.56%. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.37 earnings per share. Equities analysts anticipate that AmerisourceBergen Corporation will post $5.88 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 5th. Shareholders of record on Monday, August 21st will be paid a dividend of $0.365 per share. This represents a $1.46 annualized dividend and a yield of 1.85%. AmerisourceBergen Corporation (Holding Co)’s dividend payout ratio (DPR) is 38.02%.
A number of analysts have issued reports on the company. Zacks Investment Research downgraded AmerisourceBergen Corporation (Holding Co) from a “hold” rating to a “sell” rating in a research note on Monday, July 10th. Jefferies Group LLC started coverage on AmerisourceBergen Corporation (Holding Co) in a report on Wednesday, May 17th. They issued a “hold” rating and a $95.00 target price for the company. Mizuho lifted their target price on AmerisourceBergen Corporation (Holding Co) from $83.00 to $93.00 and gave the stock a “neutral” rating in a report on Tuesday, May 30th. Bank of America Corporation cut AmerisourceBergen Corporation (Holding Co) from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $95.76 to $94.00 in a report on Friday, June 30th. Finally, Leerink Swann set a $90.00 target price on AmerisourceBergen Corporation (Holding Co) and gave the stock a “buy” rating in a report on Monday. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $93.14.
ILLEGAL ACTIVITY WARNING: This story was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-amerisourcebergen-corporation-holding-co-abc-share-price/1470416.html.
In other AmerisourceBergen Corporation (Holding Co) news, Chairman Steven H. Collis sold 15,000 shares of the firm’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $94.76, for a total transaction of $1,421,400.00. Following the completion of the sale, the chairman now owns 253,876 shares of the company’s stock, valued at $24,057,289.76. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 27.40% of the stock is owned by company insiders.
AmerisourceBergen Corporation (Holding Co) Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with Analyst Ratings Network's FREE daily email newsletter.